LabCompass

Joel Mayerson

Medicine · The Ohio State University

OpenAlex ORCID
Established · publishing since 1999Rising activity
Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and TreatmentsManagement of metastatic bone diseaseSurgical site infection preventionSoft tissue tumor case studies

Publications

106

Citations

3,417

Est. group size

—

Recurring co-author estimate

Active years

28

Publishing since 1999

Research summary
AI-generated

Joel Mayerson's work focuses on the diagnosis and treatment of bone and soft tissue tumors, including sarcomas, benign and malignant bone lesions, and related surgical techniques such as joint replacement after tumor removal. His publications include clinical case reports, treatment guidelines, and commentary on outcome assessment methods for cancer patients, reflecting a clinical orthopedic oncology practice.

Bone and soft tissue sarcomaOrthopedic oncology surgeryBenign and malignant bone tumorsMetastatic bone disease managementClinical treatment guidelines

Publication output was highest around 2017-2019 and has notably slowed over the past five years, averaging under two publications per year.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.6/year recently
2017: 11 publications11172018: 9 publications182019: 7 publications192020: 3 publications20212022: 1 publication222023: 3 publications232024: 1 publication242025: 2 publications252026: 1 publication26
Recent publications
Publishes in
  • Current Orthopaedic Practice×6
  • Journal of Surgical Oncology×5
  • Journal of the National Comprehensive Cancer Network×3
  • Clinical Orthopaedics and Related Research×3
  • Techniques in Orthopaedics×3
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile